Jeffrey Smith in Great Falls, Montana

Home Montana Great Falls

Jeffrey Smith has Nurse Practitioner as his primary medical specialty. Their primary office is: 1101 26th St S in Great Falls, Montana.

They're a part of the: Benefis Hospitals Inc medical group which has around 295 members. You can call their office at 406-455-5000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Jeffrey Allen Smith Office Phone and Directions

Jeffrey Smith
Benefis Hospitals Inc
1101 26th St S
Great Falls, Montana 59405
406-455-5000

Patient Ratings
Please rate your experience with Jeffrey Smith below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 406-455-5000

Enter a starting address:

Healthcare Info for Jeffrey Smith

Medical School: Sorry, his university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Jeffrey Smith is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 3072923176
NPI #: 1205445095
NPI Created On: 07/28/2020
NPI Last Updated Listed as: 06/26/2023
Primary Taxonomy Code: 363LF0000X
License Number:
160455
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Emergency department visit, moderately severe problem

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $59

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 763498412

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DIABETES

Name of Drug #1: JARDIANCE

Open Associated Drug #1: 0597-0152-30